Despite advances in effective therapeutics against inflammatory cytokines such as Th2 cytokines and TSLP, a significant number of patients with allergic diseases and asthma do not respond to current therapy, highlighting a substantial unmet medical need. This evidence concerns the gene TSLP and asthma.